Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders: Evidence for association of ASCL1 with Parkinson's disease

Human Genetics

Volumn 117, Issue 6, 2005, Pages 520-527

  Ide, Masayuki ^a   Yamada, Kazuo ^a   Toyota, Tomoko ^a   Iwayama, Yoshimi ^a   Ishitsuka, Yuichi ^a   Minabe, Yoshio ^b   Nakamura, Kazuhiko ^b   Hattori, Nobutaka ^c   Asada, Takashi ^d   Mizuno, Yoshikuni ^c   Mori, Norio ^b   Yoshikawa, Takeo ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d University of Tsukuba School of Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; HOMEODOMAIN PROTEIN; POLYGLUTAMINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR PHOX2B; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; ASCL1 GENE; BIPOLAR DISORDER; CASE CONTROL STUDY; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; EYE MALFORMATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE INSERTION; GENETIC EPISTASIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN GENOME; LOCUS CERULEUS; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROPROTECTION; OCULOMOTOR NERVE; PARKINSON DISEASE; PHENOTYPE; PHOX2B GENE; PRIORITY JOURNAL; PSYCHOPATHY; SCHIZOPHRENIA;

ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PEPTIDES; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

EID: 27544513406     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-005-1342-8     Document Type: Article

References (26)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, D.C.
2. Bing G, Zhang Y, Watanabe Y, McEwen BS, Stone EA (1994) Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res 668:261-265 7704612
3. Brownstein MJ, Carpten JD, Smith JR (1996) Modulation of non-templated nucleotide addition by Taq DNA polymerase: Primer modifications that facilitate genotyping Biotechniques 20:1004-1006, 1008-1010
4. Cordell HJ, Clayton DG (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes. Am J Hum Genet 70:124-141 11719900
5. De Pontual L, Nepote V, Attie-Bitach T, Al Halabiah H, Trang H, Elghouzzi V, Levacher B, Benihoud K, Auge J, Faure C, Laudier B, Vekemans M, Munnich A, Perricaudet M, Guillemot F, Gaultier C, Lyonnet S, Simonneau M, Amiel J (2003) Noradrenergic neuronal development is impaired by mutation of the proneural HASH-1 gene in congenital central hypoventilation syndrome (Ondine's curse). Hum Mol Genet 12:3173-3180 14532329
6. Dekker MC, Bonifati V, Van Duijn CM (2003) Parkinson's disease: Piecing together a genetic jigsaw. Brain 126:1722-1733 12805097
7. Fornai F, Alessandri MG, Torracca MT, Bassi L, Corsini GU (1997) Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions. J Pharmacol Exp Ther 283:100-107 9336313
8. Gesi M, Soldani P, Giorgi FS, Santinami A, Bonaccorsi I, Fornai F (2000) The role of the locus coeruleus in the development of Parkinson's disease. Neurosci Biobehav Rev 24:655-668 10940440
9. Hattori N, Kobayashi H, Sasaki-Hatano Y, Sato K, Mizuno Y (2003) Familial Parkinson's disease: A hint to elucidate the mechanisms of nigral degeneration. J Neurol 250(Suppl 3):III2-10 14579118
10. Itokawa M, Yamada K, Yoshitsugu K, Toyota T, Suga T, Ohba H, Watanabe A, Hattori E, Shimizu H, Kumakura T, Ebihara M, Meerabux JMA, Toru M, Yoshikawa T (2003) A microsatellite repeat in the promoter of the NMDA receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia. Pharmacogenetics 13:271-278 12724619
11. Lipinski MM, Yuan J (2004) Mechanisms of cell death in polyglutamine expansion diseases. Curr Opin Pharmacol 4:85-90 15018844
12. Ludecke B, Knappskog PM, Clayton PT, Surtees RA, Clelland JD, Heales SJ, Brand MP, Bartholome K, Flatmark T (1996) Recessively inherited L-DOPA-responsive Parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 5:1023-1028 8817341
13. Marder K, Tang MX, Mejia H, Alfaro B, Cote L, Louis E, Groves J, Mayeux R (1996) Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology 47:155-160 8710070
14. Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC (1991) Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: A possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience 41:507-523 1870701
15. Ott J (2001) Neural networks and disease association studies. Am J Hum Genet 105:60-61
16. Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF (1997) Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development 124:4065-4075 9374403
17. Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF (1999) The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399:366-370 10360575
18. Pattyn A, Goridis C, Brunet JF (2000) Specification of the central noradrenergic phenotype by the homeobox gene Phox2b. Mol Cell Neurosci 15:235-243 10736201
19. Renault B, Lieman J, Ward D, Krauter K, Kucherlapati R (1995) Localization of the human achaete-scute homolog gene (ASCL1) distal to phenylalanine hydroxylase (PAH) and proximal to tumor rejection antigen (TRA1) on chromosome 12q22-q23. Genomics 30:81-83
20. Schneider RD, Excofier L (2000) Arlequin: A software for population genetics data analysis, 2 edn, version 2.000. Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva
21. Sham PC, Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105 7762987
22. Srinivasan J, Schmidt WJ (2004) Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: Neurochemical and behavioral evidence. Behav Brain Res 154:353-363 15313023
23. Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN, Blaumueller CM, Nelkin BD, Ball DW (2002) Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol 22:3129-3139 11940670
24. Toyota T, Yoshitsugu K, Ebihara M, Yamada K, Ohba H, Fukasawa M, Minabe Y, Nakamura K, Sekine Y, Takei N, Suzuki K, Itokawa M, Meerabux JMA, Iwayama-Shigeno Y, Tomaru Y, Shimizu H, Hattori E, Mori N, Yoshikawa T (2004) Association between schizophrenia with ocular misalignment and polyalanine length variation in PMX2B. Hum Mol Genet 13:551-561 14709596
25. Warner TT, Schapira AH (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 53 (Suppl 3):S16-S23 12666095
26. Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337-341 12633144